0001415889-24-024463.txt : 20241002 0001415889-24-024463.hdr.sgml : 20241002 20241002171505 ACCESSION NUMBER: 0001415889-24-024463 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241001 FILED AS OF DATE: 20241002 DATE AS OF CHANGE: 20241002 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brennan Kevin M. CENTRAL INDEX KEY: 0001971303 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40925 FILM NUMBER: 241348757 MAIL ADDRESS: STREET 1: C/O XILIO THERAPEUTICS, INC. STREET 2: 828 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Xilio Therapeutics, Inc. CENTRAL INDEX KEY: 0001840233 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 851623397 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 828 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-833-1027 MAIL ADDRESS: STREET 1: 828 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 form4-10022024_051001.xml X0508 4 2024-10-01 0001840233 Xilio Therapeutics, Inc. XLO 0001971303 Brennan Kevin M. 828 WINTER STREET SUITE 300 WALTHAM MA 02451 false true false false SVP, FINANCE AND ACCOUNTING 0 Stock Option (right to buy) 0.75 2024-10-01 4 A 0 26000 0 A 2034-09-30 Common Stock 26000 26000 D The option was granted on October 1, 2024 and will vest as to 100% of the shares underlying the option on September 30, 2025, subject to the Reporting Person's continued service to the Issuer or its subsidiaries through the vesting date. /s/ Julia Walcott, Attorney-in-Fact 2024-10-02